Walgreens Makes Abbott’s BinaxNOW COVID-19 Self Test Available Over-The-Counter at Stores Nationwide
As part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it has entered into an agreement with Abbott to sell the BinaxNOW Rapid Antigen Self Test over-the-counter in Walgreens stores nationwide. Beginning this week, this test will be available for purchase on Walgreens.com, and later this week, it will be available for purchase in-store, for curbside pick-up, and same day delivery. This test will be available nationwide for $23.99 (MSRP).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210419005269/en/
BinaxNOW Rapid Antigen Self Test (Photo: Business Wire)
“Even as vaccines become more widely available, COVID-19 testing remains a critical tool to keep our communities safe. The addition of this over-the-counter test in-store will help ensure our customers have access to testing solutions when and how they need it – at home or at one of our conveniently located testing sites,” said John Standley, president, Walgreens. “Working with Abbott and other partners, Walgreens now offers the most comprehensive suite of COVID-19 diagnostic testing options in America, helping encourage consistent, widespread testing.”
Walgreens has made significant strides to increase on-site COVID-19 testing capacity at more than 5,500 Walgreens pharmacies, with more than half of these locations located in socially vulnerable areas. By May, Walgreens will expand testing to 6,000 drive-thru testing sites with half of these sites offering the no-cost, rapid Abbott ID NOW COVID-19 test. This announcement builds upon Walgreens commitment to provide greater access to testing, helping reduce the spread of COVID-19 and improve the health of communities.
“The BinaxNOW Self Test opens the door for Americans to buy an accurate and affordable test on their own terms, when and where they need it,” said Andrea F. Wainer, executive vice president of Abbott’s rapid and molecular diagnostics business. “Together with vaccines and like-minded partners such as Walgreens, we can help people get back to doing what they love – like spending time with friends and family.”
Customers can self-administer the test collection using a short nasal swab (not the deep and invasive nasopharyngeal swab) and check test results in 15 minutes. The BinaxNOW COVID-19 Self Test is the most studied rapid antigen in the U.S., having first been approved in the U.S. for professional use in August 2020. The Self Test is the identical format and technology as the professional test and will come in a two-count box to meet the U.S. Food and Drug Administration’s (FDA) serial (frequent) testing requirements for non-prescription, over-the-counter purchase.